Nutri Pharmaceuticals Research, Inc.
NRPR
$0.03
$0.000.00%
OTC PK
| 12/31/2003 | |||||
|---|---|---|---|---|---|
| Revenue | 125.90K | ||||
| Total Other Revenue | -- | ||||
| Total Revenue | 125.90K | ||||
| Cost of Revenue | 106.90K | ||||
| Gross Profit | 19.00K | ||||
| SG&A Expenses | 161.10K | ||||
| Depreciation & Amortization | 5.60K | ||||
| Other Operating Expenses | -- | ||||
| Total Operating Expenses | 273.60K | ||||
| Operating Income | -147.70K | ||||
| Income Before Tax | -152.00K | ||||
| Income Tax Expenses | -- | ||||
| Earnings from Continuing Operations | -152.00K | ||||
| Earnings from Discontinued Operations | -- | ||||
| Extraordinary Item & Accounting Change | -- | ||||
| Minority Interest in Earnings | -- | ||||
| Net Income | -152.00K | ||||
| EBIT | -147.70K | ||||
| EBITDA | -142.10K | ||||
| EPS Basic | -0.94 | ||||
| Normalized Basic EPS | -0.58 | ||||
| EPS Diluted | -0.94 | ||||
| Normalized Diluted EPS | -0.58 | ||||
| Average Basic Shares Outstanding | 162.60K | ||||
| Average Diluted Shares Outstanding | 162.60K | ||||
| Dividend Per Share | -- | ||||
| Payout Ratio | -- | ||||